Robert W Postma - Net Worth and Insider Trading
Robert W Postma Net Worth
The estimated net worth of Robert W Postma is at least $102,008 dollars as of 2024-11-13. Robert W Postma is the Director of Alaunos Therapeutics Inc and owns about 41,636 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $102,008. Details can be seen in Robert W Postma's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert W Postma has not made any transactions after 2022-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert W Postma
Robert W Postma Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert W Postma owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .
Click here to see the complete history of Robert W Postma’s form 4 insider trades.
Insider Ownership Summary of Robert W Postma
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2022-11-29 | director |
Robert W Postma Latest Holdings Summary
Robert W Postma currently owns a total of 1 stock. Robert W Postma owns 41,636 shares of Alaunos Therapeutics Inc (TCRT) as of November 29, 2022, with a value of $102,008.
Latest Holdings of Robert W Postma
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2022-11-29 | 41,636 | 2.45 | 102,008 |
Holding Weightings of Robert W Postma
Robert W Postma Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert W Postma has made a total of 2 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 5,000 shares on November 29, 2022, which cost Robert W Postma around $487,500.
Insider Trading History of Robert W Postma
- 1
Robert W Postma Trading Performance
GuruFocus tracks the stock performance after each of Robert W Postma's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert W Postma is -21.73%. GuruFocus also compares Robert W Postma's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert W Postma within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert W Postma's insider trading performs compared to the benchmark.
Performance of Robert W Postma
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.66 | | | | | |
| Relative Return to S&P 500(%) | 4.02 | | | | | |
Robert W Postma Ownership Network
Ownership Network List of Robert W Postma
Ownership Network Relation of Robert W Postma
Robert W Postma Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
Robert W Postma is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, Robert W Postma made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
Robert W Postma Mailing Address
Above is the net worth, insider trading, and ownership report for Robert W Postma. You might contact Robert W Postma via mailing address: 141 Mecox Road, Water Mill Ny 11976.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
